# "

Glycopeptide.

Narrow spectrum bactericidal (slow) against blood stream infections, endocarditis, pneumonia, and others caused by MRSA.

Inhibits terminal D-Ala.

Intravenous and requires blood monitoring.

Oral form is for Clostridium difficile.

Red neck syndrome.

Oto and renal toxicity.

The core of lipoglycopeptides, such as Telavancin, Oritavancin, and Dalbavancin. 
